Apella Capital, LLC Abb Vie Inc. Transaction History

Apella Capital, LLC

$2.18 Billion
Q2 2024

A detailed history of Apella Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Apella Capital, LLC holds 7,569 shares of ABBV stock, worth $1.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,569

Previous 7,365 2.77%

Holding current value

$1.33 Million

Previous $1.34 Million 3.21%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $31,577 - $36,875	204 Added 2.77%	7,569 $1.3 Million
Q1 2024 Apr 10, 2024	BUY	$159.82 - $182.1 $16,621 - $18,938	104 Added 1.43%	7,365 $1.34 Million
Q4 2023 Jan 05, 2024	SELL	$137.6 - $154.97 $20,777 - $23,400	-151 Reduced 2.04%	7,261 $1.13 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $42,080 - $48,714	315 Added 4.44%	7,412 $1.1 Million
Q2 2023 Jul 06, 2023	SELL	$132.51 - $164.9 $346,116 - $430,718	-2,612 Reduced 26.9%	7,097 $956,000

Q4 2022 Jan 10, 2023	SELL	$138.31 - $165.87 $59,196 - $70,992	-428 Reduced 4.22%	9,709 $0
Q3 2022 Oct 11, 2022	BUY	$134.21 - $153.93 $165,883 - $190,257	1,236 Added 13.89%	10,137 $1.36 Million
Q2 2022 Jul 08, 2022	BUY	$137.62 - $174.96 $44,726 - $56,862	325 Added 3.79%	8,901 $1.36 Million
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $151,777 - $188,312	1,150 Added 15.49%	8,576 $1.39 Million
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $36,848 - $46,623	343 Added 4.84%	7,426 $1.01 Million
Q3 2021 Jan 18, 2022	SELL	$106.4 - $120.78 $20,535 - $23,310	-193 Reduced 2.65%	7,083 $764,000
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $27,876 - $31,644	262 Added 3.74%	7,276 $797,000
Q2 2021 Jan 18, 2022	SELL	$105.21 - $117.21 $20,936 - $23,324	-199 Reduced 2.76%	7,014 $790,000
Q2 2021 Jul 02, 2021	BUY	$105.21 - $117.21 $112,364 - $125,180	1,068 Added 17.38%	7,213 $812,000
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $14,731 - $16,217	144 Added 2.4%	6,145 $665,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $8,591 - $10,083	-100 Reduced 1.64%	6,001 $526,000
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $15,334 - $20,519	209 Added 3.55%	6,101 $599,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $380,034 - $576,178	5,892 New	5,892 $449,000

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Abb Vie Inc. Transaction History